SCYNEXIS, Inc. ( SCYX) - Stock Earnings
SCYX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
SCYX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.6 million USD | 334000 USD |
| 2025Q4 | 12.3 million USD | 18.6 million USD |
| 2026Q1 | -21.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SCYX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 67.0 million USD | 140.1 million USD |
| 2024 | -21.3 million USD | 3.7 million USD |
| 2025 | -8.6 million USD | 20.6 million USD |
| 2026 Est. | — | — |
SCYX
Price: $3.96
Earnings Per Share: -0.48 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 45800
Ebitda: -8.0 millionMarket Capitalization: 27.9 million